(MENAFN- Ameliorate Digital Consultancy)
The global radiosurgery and radiotherapy robots market is set to enjoy a valuation of US$ 5.8 billion in 2022. Worldwide sales of radiosurgery and radiotherapy robots are predicted to increase at a steady CAGR of 4.6% to reach a market valuation of US$ 7.1 billion by the end of 2026.
The employment of robots in radiotherapy is being driven by the high requirement for precise and secure delivery of focused high medication doses to the targeted area. The main benefits of radiosurgery and radiotherapy robotic systems are their adaptability in a beam setup and their capacity to account for targeted motion.
Download Free Sample Copy of This Report:
Key Takeaways from Market Study
The global radiosurgery and radiotherapy robots market is to reach a valuation of US$ 5.8 billion by 2026. Demand for radiosurgery and radiotherapy robots is expected to increase at a CAGR of 4.6% from 2022 to 2026. Radiosurgery and radiotherapy robot sales growth is aided by hospitals treating patients with tumours of cancerous or non-cancer type. North America is handsomely leading the global radiosurgery and radiotherapy robots market.
According to Fact.MR's analyst, “ t he manner that radiosurgery and radiotherapy therapies are reimbursed varies greatly depending on the local government. However, the improved environment is motivating more patients to choose these therapies, which is expected to boost market expansion ” .
Winning Strategy
Many companies are emphasizing organic growth strategies, including new product releases, product approvals, and other factors such as patents and promotional events.
One of the growth strategies seen in the market is mergers and acquisitions, along with partnerships and collaborations. Market participants now have the opportunity to expand their businesses due to activities such as the creation of new products and the improvement of existing ones.
Digital Surgery, a pioneer in surgical artificial intelligence, data, and analytics, was purchased by Medtronic (U.S.) in February 2020. As a result, the portfolio and platform for robot-assisted surgery at Medtronic have expanded.
Share Your Requirements & Get Customized Reports:
Key Companies Profiled:
Accuray, Inc. Best Theratronics Ltd. BrainLab AG Elekta AB Huiheng Medical, Inc. Masep Medical Science & Technology Development (Shenzhen) Co., Ltd. Neusoft Medical Systems Co., Ltd. Varian Medical Systems, Inc. ViewRay, Inc.
Full Access to this Report Is Available:
Key Segments :
By Product : X-ray Based Gamma-ray Based Proton-beam Based
By End Use :
Key Questions Covered in the Radiosurgery and Radiotherapy Robots Market Report
What is the projected value of the Radiosurgery and Radiotherapy Robots factors Industry in 2022? At what rate will the global Radiosurgery and Radiotherapy Robots factors market size grow until 2032? Which are the factors hampering the growth of Radiosurgery and Radiotherapy Robots factors? Which region is expected to lead in the global Radiosurgery and Radiotherapy Robots factors market By 2032? Which are the factors driving the Radiosurgery and Radiotherapy Robots factors Industry during the forecast period? What is the expected market value of the Radiosurgery and Radiotherapy Robots factors market during the forecast period?
Regional Analysis For Radiosurgery and Radiotherapy Robots Market:
APAC (Japan, China, South Korea, Australia, India, and the rest of APAC; the rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) North America (USA, Canada and Mexico) South America (Brazil, Chile, Argentina, Rest of South America) MEA (Saudi Arabia, United Arab Emirates, South Africa)
For More Insights of Fact.MR Trending Report:-
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email:
subscribe newsletter for the latest updates
MENAFN19032023004660010643ID1105811596
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.